ERBB2 and ovarian carcinoma: To elucidate whether baicalein inhibits the growth of aggressive ovarian cancer cells, we first assessed the cell viability of highly invasive human SKOV-3 and TOV-21G ovarian cancers with different ErbB2 levels treated with baicalein.